Minireviews
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 16, 2023; 11(5): 979-988
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.979
Non-clostridium difficile induced pseudomembranous colitis
Gowthami Sai Kogilathota Jagirdhar, Salim Surani
Gowthami Sai Kogilathota Jagirdhar, Department of Medicine, Saint Michaels Medical Center, Newark, NJ 07102, United States
Salim Surani, Department of Pulmonary, Critical Care & Pharmacy, Texas A&M University, Kingsville, TX 78363, United States
Author contributions: Jagirdhar GSK contributed to literature review, writing the original manuscript; Surani S contributed to writing the original manuscript, revising the paper, and approving the final version.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salim Surani, FCCP, MD, MS, Professor, Department of Pulmonary, Critical Care & Pharmacy, Texas A&M University, 700 University Blvd, Kingsville, TX 78363, United States. srsurani@hotmail.com
Received: November 2, 2022
Peer-review started: November 2, 2022
First decision: January 3, 2023
Revised: January 9, 2023
Accepted: January 20, 2023
Article in press: January 20, 2023
Published online: February 16, 2023
Abstract

Pseudomembranous colitis is severe inflammation of the inner lining of the colon due to anoxia, ischemia, endothelial damage, and toxin production. The majority of cases of pseudomembranous colitis are due to Clostridium difficile. However, other causative pathogens and agents have been responsible for causing a similar pattern of injury to the bowel with the endoscopic appearance of yellow-white plaques and membranes on the mucosal surface of the colon. Common presenting symptoms and signs include crampy abdominal pain, nausea, watery diarrhea that can progress to bloody diarrhea, fever, leukocytosis, and dehydration. Negative testing for Clostridium difficile or failure to improve on treatment should prompt evaluation for other causes of pseudomembranous colitis. Bacterial infections other than Clostridium difficile, Viruses such as cytomegalovirus, parasitic infections, medications, drugs, chemicals, inflammatory diseases, and ischemia are other differential diagnoses to look out for in pseudomembranous colitis. Complications of pseudomembranous colitis include toxic megacolon, hypotension, colonic perforation with peritonitis, and septic shock with organ failure. Early diagnosis and treatment to prevent progression are important. The central perspective of this paper is to provide a concise review of the various etiologies for pseudomembranous colitis and management per prior literature.

Keywords: Infections, Pseudomembranous colitis, Gastroenteritis, Gastrointestinal diseases, Non-Clostridium difficile, Enterocolitis, Digestive system diseases

Core Tip: Pseudomembranous colitis (PMC) is mostly caused by Clostridium difficile infection (CDI). The incidence of CDI-related PMC is 3%-8% and is increasing. Other than CDI, ischemia, infections, medications, and inflammatory conditions can cause PMC. Infections from S. aureus, E. coli, Klebsiella, and Strongyloidiasis may also cause PMC. Non-infectious causes of PMC include chemical endoscope cleaning agents, intestinal ischemia, drug abuse from cocaine, inflammatory bowel disease, and microscopic colitis. Understanding various causes of pseudomembranous colitis helps avoid over usage of antibiotics and focus on targeted therapy and early diagnosis. This is a concise review of non-CDI pseudomembranous colitis.